Solanezumab
Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab has the potential for the research of Alzheimer’s disease[1].
Product Specifications
CAS Number
[955085-14-0]
Product Name Alternative
LY-2062430
UNSPSC
12352203
Target
Amyloid-β
Type
Inhibitory Antibodies
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/solanezumab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Solanezumab]
Molecular Weight
(144.8 kDa)
References & Citations
[1][1]Honig LS, et al. Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease. N Engl J Med. 2018 Jan 25;378 (4) :321-330.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1029008-01 0.02 mg (E-Coli)
Recombinant Tomato bushy stunt virus RNA silencing suppressor p19 (ORF4)
Ask
View Details MBS1029008-02 0.1 mg (E-Coli)
Recombinant Tomato bushy stunt virus RNA silencing suppressor p19 (ORF4)
Ask
View Details MBS1029008-03 0.02 mg (Yeast)
Recombinant Tomato bushy stunt virus RNA silencing suppressor p19 (ORF4)
Ask
View Details MBS1029008-04 0.1 mg (Yeast)
Recombinant Tomato bushy stunt virus RNA silencing suppressor p19 (ORF4)
Ask
View Details MBS1029008-05 0.02 mg (Baculovirus)
Recombinant Tomato bushy stunt virus RNA silencing suppressor p19 (ORF4)
Ask
View Details